| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,717,900 | 1,740,800 | 1,438,900 | 1,785,600 | | Cost of Revenue | 668,700 | 1,038,400 | 888,000 | 960,900 | | | Gross Profit | 1,049,200 | 702,400 | 550,900 | 824,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 834,700 | 491,900 | 445,600 | 630,900 | | Non Recurring | 1,500 | 9,200 | 36,500 | 501,900 | | Others | 8,500 | 8,400 | 8,300 | 12,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 204,500 | 192,900 | 60,500 | (320,400) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,900 | (9,600) | (4,500) | 8,900 | | Earnings Before Interest And Taxes | 211,400 | 183,300 | 56,000 | (311,500) | | Interest Expense | 55,100 | 53,400 | 52,500 | 57,900 | | Income Before Tax | 156,300 | 129,900 | 3,500 | (369,400) | | Income Tax Expense | 31,100 | 29,300 | (5,400) | (89,800) | | Minority Interest | (1,100) | (2,300) |
-
| (1,700) | | | | Net Income From Continuing Ops | 127,500 | 98,300 | 8,900 | (281,300) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 124,100 | 98,300 | 8,900 | (281,300) | | Preferred Stock And Other Adjustments |
-
| 1,500 | (1,500) |
-
| | | Net Income Applicable To Common Shares | $124,100 | $99,800 | $7,400 | ($281,300) |
|
0.18% Nasdaq 
0.42%
Income Statement
